✦ LIBER ✦

Molecularly targeted therapy in hepatocellular carcinoma

✍ Scribed by Hung Huynh

Book ID: 113489194
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 210 KB
Volume: 80
Category: Article
ISSN: 0006-2952
DOI: 10.1016/j.bcp.2010.03.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecularly targeted therapy for hepatoc

Molecularly targeted therapy for hepatocellular carcinoma

✍ Shinji Tanaka; Shigeki Arii 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

Current status of molecularly targeted t

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

✍ Shinji Tanaka; Shigeki Arii 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 420 KB

Current status of molecularly targeted t

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

✍ Masatoshi Kudo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 469 KB

Molecularly targeted therapy for hepatoc

Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects

✍ Shigeki Arii 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 64 KB

Molecular targeted therapy for hepatocel

Molecular targeted therapy for hepatocellular carcinoma

✍ Melanie Thomas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 150 KB

Development of sorafenib and other molec

Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma

✍ Andrew X. Zhu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

## Abstract It is well appreciated that hepatocellular carcinoma (HCC) represents one of the most challenging malignancies of worldwide importance. In fact, HCC is the fifth most common cancer and the third most common cause of cancer‐related death globally. The incidence rates for HCC in the U.S.